Open-house Lenograstim rebate agreement
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-30 - Lenograstim
Opportunity Score
Why this score?
Opportunity
46 / 100
Complexity
58 / 100
Risk factors
Portal submission is not allowed; contracts must be sent by email with qualified electronic signature or by post, which...
Participation is restricted to pharmaceutical undertakings for the relevant product, with seat and authorisation requir...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Dec 2027
- Conclusion of rebate agreements for the active substance Lenograstim under an open-house procedure.
- Supply of pharmaceutical products (CPV 33600000).
Show full summary
Open-house supply arrangement for Lenograstim pharmaceutical products in Germany, led by Techniker Krankenkasse with HEK and hkk participating. The notice states no exclusivity, no individual negotiations, and uniform terms for all eligible pharmaceutical companies. Contracting can occur throughout the term, but the agreement ends no later than 31.12.2027. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, with portal communication used for questions. No contract value is stated.
Risks
Portal submission is not allowed; contracts must be sent by email with qualified electronic signature or by post, which...
Participation is restricted to pharmaceutical undertakings for the relevant product, with seat and authorisation requir...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Applicant must be a pharmaceutical undertaking within the meaning of Section 4(18) AMG for the offered medicinal products.
- Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
- Applicant must hold a valid marketing authorisation for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open-house Lenograstim rebate agreement
Open-house contract for pharmaceutical rebate agreements under Section 130c(1) SGB V for the active substance Lenograstim. Scope is nationwide in Germany. The lot information comes from structured data and the notice text.
Location
Duration
Category
Deadline
Award details
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Lenograstim im Rahmen eines Open-House-Verfahrens.
Value note
Show original TED data
Original lot title
Open-House-Biologika-Rabattverträge 2025-30 - Lenograstim
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Lenograstim im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 23 Apr 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 282722-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
46 / 100
Complexity
58 / 100
Risk factors
Portal submission is not allowed; contracts must be sent by email with qualified electronic signature or by post, which...
Participation is restricted to pharmaceutical undertakings for the relevant product, with seat and authorisation requir...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications